Vancouver biotech anchor AbCellera has broken ground at the Mount Pleasant address that will soon be home…
sciencecitySeptember 19, 2022
Organ-on-chip devices (OoCs) provide more nuanced insights into (patho)physiological processes of the human body than…
sciencecitySeptember 16, 2022
Algernon Pharmaceuticals, a clinical stage pharmaceutical development company is pleased to announce that it has…
sciencecitySeptember 16, 2022
My entire life has been influenced by the bridge between science and art. I graduated…
sciencecitySeptember 15, 2022
Vasculitis is a disease characterized by inflammation of blood vessels which carry oxygen to critical…
sciencecitySeptember 15, 2022
Hepatitis B virus (HBV) can rapidly replicate in the hepatocytes after transmission, leading to chronic…
sciencecitySeptember 14, 2022
Dr. Fabio Rossi is among 102 new Fellows elected to the Royal Society of Canada (RSC) in…
sciencecitySeptember 13, 2022
Simon Fraser University’s core facility, 4D LABS has received a generous investment of $1,921,700 from Western Economic Diversification…
sciencecityNovember 28, 2018
On October 26, UBC’s BIOMOD (biomolecular design) team won third place at the BIOMOD Jamboree…
sciencecityNovember 25, 2018
For more than a decade, MSFHR invested $22.8 million in critical infrastructure projects to enhance…
sciencecityNovember 22, 2018
Aspect Biosystems, a leader in the field of 3D bioprinting and tissue engineering, has received…
sciencecityNovember 20, 2018
The medical application of cannabis has been a calling card for marijuana legalization advocates for…
sciencecityNovember 20, 2018
A new discovery by an international research team—co-led by UBC Canada 150 Research Chair Josef…
sciencecityNovember 14, 2018
Prostate cancer researchers find new target for drug therapy. Prostate cancer is the most common…
sciencecityNovember 13, 2018
Over the next 10 years, studies suggest, B.C. will lose two million jobs—but will gain…
sciencecityNovember 12, 2018
